Sartorius AG Pref SRT3

Sartorius has delivered a positive 1 year share price gain alongside fresh attention on bioprocess automation, which puts a sharper spotlight on whether the current valuation lines up with the cash flows investors can reasonably expect from the business. With the stock last closing at €261.00, the key question is how that price compares with an intrinsic value estimate built from its own cash generation. Over 5 years the share price has fallen 52.8%, which makes the gap between past investor...

OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director Oxford, UK – 16 October 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Dr Joachim Kreuzburg as an Independent Non-Executive Director, effective on 23 November 2026. Dr Kreuzburg has more than 20 years of public company leadership experience in the global life sciences industry. He was Chair of the Executive Board and Chief Executive Officer of Sartorius A

Boost ROI with modular, customized systems that scale flexibly, cut cleaning and contamination costs, speed fill-finish, and localize sourcing to reduce tariff and supply-chain risks.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "Single-Use Assemblies Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global single-use assemblies market is experiencing rapid growth, driven by expanding biopharmaceutical manufacturing, increased investment in life sciences research and devel

Boost ROI with scalable, high-throughput 3D platforms that cut variability and per-sample costs, maximize limited cells, and localize production to offset tariffs.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "3D Cell Culture Technologies Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global 3D cell culture technologies market is experiencing rapid expansion, supported by growing pharmaceutical research, increased investment in regenerative medicine, and demand for more

Boost ROI via automation, contamination control, premium consumables, targeted R&D, strategic acquisitions and localized manufacturing to offset tariffs.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "Cell Culture Consumables and Equipment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global cell culture consumables and equipment market is experiencing strong growth as pharmaceutical, biotechnology and academic research organizations expand their work in biologics, vacc

Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Cell Culture Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global cell culture market is experiencing strong growth, supported by expanding life sciences research, increased academic funding and continued development across the biopharmaceutical industry. The market is projected to rise from $31.25 billion in 2025 to $33.81 billion in 2026, representing a compound annual growth rate (CAGR) of 8.2%. Established use of cell

Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Continuous Bioprocessing Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global continuous bioprocessing market is experiencing exponential growth as biopharmaceutical manufacturers invest in more efficient, scalable and automated production technologies. The market is projected to increase from $0.38 billion in 2025 to $0.46 billion in 2026, representing a compound annual growth rate (CAGR) of 21.9%. Historical marke

Boost ROI via partnerships, process intensification, single-use systems, modular bioreactors, efficient purification and capacity expansionDublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Industrial Bioprocessing Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global industrial bioprocessing market is experiencing strong growth as pharmaceutical manufacturers, biotechnology companies and industrial producers invest in scalable, efficient and sustainable production t

Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Bioprocessing Monitoring Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global bioprocessing monitoring market is experiencing rapid growth as pharmaceutical manufacturers, biotechnology companies and research laboratories increase their use of real-time process control technologies. The market is projected to grow from $11.55 billion in 2025 to $12.75 billion in 2026, representing a compound annual growth rate (CAGR

Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Bioprocessing Supplies Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global bioprocessing supplies market is experiencing steady growth as pharmaceutical and biotechnology manufacturers increase production capacity for biologics, biosimilars, vaccines, and other advanced therapies. The market is projected to grow from $10.31 billion in 2025 to $10.73 billion in 2026, representing a compound annual growth rate (CAGR)

Boost ROI with AI/ML controls, biosensing, closed-loop processing, DCS, sensors, perfusion, single-use systems, emerging-market expansion and modular pricing.Dublin, Oct. 12, 2026 (GLOBE NEWSWIRE) -- "Bioprocess Automation Global Market Opportunities and Strategies to 2035" has been added to ResearchAndMarkets.com's offering. The global bioprocess automation market is experiencing strong growth as biopharmaceutical manufacturers increasingly adopt advanced process control technologies to improve

Fresh attention on Sartorius (XTRA:SRT3) comes after a 281 page Research and Markets study on cell based assays named the group among 54 profiled life science suppliers. The latest share price of €260.0 comes after a 30 day share price return of 11.25% and a year to date share price return of 4.92%. The 1 year total shareholder return of 20.17% contrasts with a 5 year total shareholder return that declined 49.45%, suggesting recent momentum in Sartorius is building after a tougher multi year...

281-Page Report Tracks Post-Pandemic Research Growth Across Pharma, Research and Industry/Cosmetic Users as 3D Assays, Automation and Immuno-oncology Reshape Drug DiscoveryDublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- "Cell-Based Assay & High Content Screening Market 2025-2029 - Forecasts by User and Product, with Executive and Consultant Guides" has been added to ResearchAndMarkets.com's offering. Research and Markets has published Cell-Based Assay & High Content Screening Market 2025-2029 - Foreca

Opportunities include automated closed systems, AI-enabled quality control, single-cell and cell therapy workflows, precision medicine, advanced diagnostics and emerging-market expansion.Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Cell Isolation/Cell Separation Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The market research report examines the global Cell Isolation/Cell Separation Market, which is projected to reach USD 6.97 billion in 2026 and grow a

Reusable Bioreactors Gain Momentum as Biologics, Personalized Therapies and Vaccine Production Drive Automation and Scalable ManufacturingDublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Reusable Bioreactors Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Reusable Bioreactors Market to Reach USD 24.7 Billion by 2035 as Biologics Manufacturing Expands The global reusable bioreactors market was valued at US

Cell Culture Media Market Gains Momentum as Serum-Free Formulations, Biologics and Cell Therapies Drive DemandDublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Cell Culture Media Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Cell Culture Media Market to Reach USD 10.8 Billion by 2035, Driven by Biopharmaceutical Innovation The global cell culture media market was valued at USD 3.9 billion in 2025 and is

Biologics, stricter purity rules and flexible manufacturing are driving demand for single-use, automated and continuous filtration, advanced membranes and sustainable systems.Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Pharmaceutical Filtration - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Pharmaceutical Filtration was estimated at US$8.0 Billion in 2025 and is projected to reach US$23.4 Billion by 2032, growing at a CAGR of 16.7% f

Bioreactors Market Gains Momentum as Single-Use Systems, Automation and Advanced Therapies Reshape BiomanufacturingDublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Bioreactors Market Opportunity, Growth Drivers, Industry Trend Analysis and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Bioreactors Market to Reach USD 38.9 Billion by 2035 as Advanced Biomanufacturing Expands The global bioreactors market was valued at USD 13.8 billion in 2025 and is projected to reach

Europe’s cell therapy sector is shifting to closed, automated systems, creating opportunities in AI monitoring, modular scale-up, CAR-T/ATMP production and decentralized manufacturingDublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Europe Automated and Closed Cell Therapy Processing Systems Market Size, Share & Industry Analysis Report by Type, Scale, Workflow, Country Outlook and Forecast, 2026-2033" has been added to ResearchAndMarkets.com's offering. The Europe automated and closed cell therapy pr

Demand is rising for real-time biomolecular analysis in drug discovery and diagnostics, driven by SPR/BLI advances, automation, high-throughput screening and biomarker research.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Label-free Array Systems - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Label-free Array Systems was valued at US$1.8 Billion in 2024 and is projected to reach US$2.4 Billion by 2030, growing at a CAGR of 5.6% from 2